Compounder dossier
Belmar Pharma Solutions
Belmar is important public-regulatory context because it spans both 503A and 503B models. It is not a current direct API integration, but it is a relevant workflow/reference partner for pharmacy routing and compliance modeling.
Public facts
- Belmar publicly states it operates multiple 503A compounding pharmacies and 503B outsourcing facilities.
- Public facilities page says Belmar ships to all 50 U.S. states.
- Public 503A/503B explainer distinguishes patient-specific 503A compounding from 503B outsourcing facility production.
Routing rules
- Direct API/LifeFile integration is not active in the local dossier; treat Belmar as portal, Surescripts, or workflow-reference only until their posture changes.
- Keep 503A and 503B products separated in public docs because the legal order path and ship-to-clinic behavior differ.